1. Ellfolk M, Leinonen MK, Gissler M, et al. Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol. 2021 Nov;77(11):1737–45.
2. Andrade C. Gestational and Neurodevelopmental Outcomes Associated with Antipsychotic Drug Exposure During Pregnancy. J Clin Psychiatry. 2021. https://www.psychiatrist.com/jcp/psychopharmacology/gestational-and-neurodevelopmental-outcomes-associated-with-antipsychotic-drug-exposure-during-pregnancy/
3. Viguera AC, Freeman MP, Góez-Mogollón L, et al. Reproductive Safety of Second-Generation Antipsychotics: Updated Data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. J Clin Psychiatry. 2021 Aug 3;82(4):35609.
4. Damkier P, Christensen LS, Broe A. Patterns and predictors for prescription of psychotropics and mood-stabilizing antiepileptics during pregnancy in Denmark 2000-2016. Br J Clin Pharmacol. 2018 Nov;84(11):2651–62.
5. Park Y, Huybrechts KF, Cohen JM, et al. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States. PS. 2017 Nov;68(11):1112–9.
6. Anderson KN, Ailes EC, Lind JN, et al. Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997–2011. Schizophrenia Research. 2020 Jan;215:81–8.
7. Seki R, Hashimoto T, Tanaka M, et al. Relapse of psychiatric symptoms after discontinuation of antipsychotics in pregnant women with schizophrenia: a retrospective study. CNPT. 2020 Oct 2;11(0):61–6. https://www.jstage.jst.go.jp/article/cnpt/11/0/11_61/_pdf/-char/ja
8. Faramarzi M, Kheirkhah F, Barat S, Cuijpers P, O’Connor E, Ghadimi R, et al. Prevalence and Factors related of psychiatric symptoms in low risk pregnancy. Caspian J Intern Med. 2020;11(2). https://doi.org/10.22088/cjim.11.2.211
9. Chokhawala KP, Stevens L. Antipsychotic Medications. [Updated 2023 Feb 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519503/
10. Hálfdánarson Ó, Cohen JM, Karlstad Ø, et al. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Mental Health. 2021 Nov 22;ebmental-2021-300311.
11. RCP. Antipsychotics in pregnancy | Royal College of Psychiatrists. Royal College of Psychiatrists. 2018. https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/antipsychotics-in-pregnancy.
12. Ellfolk M, Leinonen MK, Gissler M, et al. Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol. 2020 Jan;76(1):107–15.
13. Heinonen E, Forsberg L, Nörby U, et al. Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden. CNS Drugs. 2022 May;36(5):529–39.
14. Park Y, Hernandez-Diaz S, Bateman BT, et al. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. American Journal of Psychiatry. 2018 Jun;175(6):564–74.